Abstract
The use of medicinal plants as an alternative mean of treating various diseases has drawn the attention of several researchers. The desire to find lasting solutions to epilepsy among humans increases every day. Thus, this work was aimed at investigating the potential capacity of the studied phytochemicals in Alsophila spinulosa against human 4-aminobutyrate-aminotransferase as well as to predict the nonbonding interactions involved in the studied complexes. In this work, ten compounds with biological activities were selected and studied using molecular docking method. The molecules selected obtained from A. spinulosa leaves were optimized and various descriptors that described the anti-4-aminobutyrate-aminotransferase features were obtained. More so, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one (compound 9) with highest binding affinity proved to have greater strength to inhibit 4-aminobutyrate-aminotransferase thereby downregulating epilepsy than other studied compounds and the reference drug (clobazam). The ADMET features of both compound 9 and clobazam were explored and reported.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.